|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 51.96L 5.96Cr 45.45L 41.92L 38.72L 73.47L 50Cr 74.71L 5.01Cr 1.97Cr 24Cr 1.95Cr 1.91Cr 84Cr | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04Cr 12Cr 91.37L 84.28L 77.84L 1.48Cr 100Cr 1.5Cr 10Cr 3.95Cr 49Cr 3.92Cr 3.84Cr 168.73Cr | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 9L | ||
| -2.33% | -2.09% | +49.88% | +170.51% | 1,06000Cr | ||
| -0.82% | -2.30% | +63.79% | +62.00% | 62TCr | ||
| -0.73% | -4.98% | +28.91% | +82.99% | 44TCr | ||
| +0.33% | -1.17% | +31.07% | +27.09% | 33TCr | ||
| -0.02% | -2.85% | +29.15% | +45.24% | 28TCr | ||
| -3.89% | -11.22% | +22.81% | +27.30% | 27TCr | ||
| +0.66% | -1.42% | -26.59% | -37.71% | 22TCr | ||
| -0.06% | -2.88% | +23.07% | +62.33% | 20TCr | ||
| -3.72% | -1.10% | +18.41% | +70.56% | 16TCr | ||
| Average | -1.18% | -3.25% | +26.72% | +56.70% | 35.74TCr | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 88.93L 10Cr 77.78L 71.75L 66.26L 1.26Cr 85Cr 1.28Cr 8.57Cr 3.37Cr 42Cr 3.34Cr 3.27Cr 143.64Cr | 99.1L 11Cr 86.68L 79.95L 73.84L 1.4Cr 95Cr 1.42Cr 9.55Cr 3.75Cr 47Cr 3.72Cr 3.64Cr 160.06Cr |
| Net income | 7L 76.24L 6L 5L 5L 9L 6.34Cr 10L 64.11L 25.18L 3.12Cr 24.97L 24.43L 11Cr | 8L 87.3L 7L 6L 6L 10.77L 7.26Cr 10.95L 73.41L 28.83L 3.58Cr 28.59L 27.97L 12Cr |
| Net Debt | 41.47L 4.75Cr 36.27L 33.46L 30.9L 58.64L 40Cr 59.62L 4Cr 1.57Cr 19Cr 1.56Cr 1.52Cr 67Cr | 52.5L 6.02Cr 45.92L 42.36L 39.12L 74.23L 50Cr 75.48L 5.06Cr 1.99Cr 25Cr 1.97Cr 1.93Cr 85Cr |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















